In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Ironwood Pharmaceuticals Inc’s stock clocked out at $3.80, up 2.43% from its previous closing price of $3.71. In other words, the price has increased by $2.43 from its previous closing price. On the day, 1.1 million shares were traded. IRWD stock price reached its highest trading level at $4.0 during the session, while it also had its lowest trading level at $3.7.
Ratios:
To gain a deeper understanding of IRWD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.91. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Market Perform rating and assigned the stock a target price of $5.
On August 08, 2024, CapitalOne Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $4.
On January 17, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.Craig Hallum initiated its Buy rating on January 17, 2024, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 27 ’24 when Davis Andrew bought 60,434 shares for $4.00 per share.
Davis Andrew sold 5,360 shares of IRWD for $21,869 on Nov 18 ’24. The SVP, Chief Business Officer now owns 284,685 shares after completing the transaction at $4.08 per share. On Nov 18 ’24, another insider, Emany Sravan Kumar, who serves as the SVP, COO and CFO of the company, sold 11,001 shares for $4.08 each. As a result, the insider received 44,884 and left with 309,572 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 608106368 and an Enterprise Value of 1120366336. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61. Its current Enterprise Value per Revenue stands at 2.961 whereas that against EBITDA is 11.503.
Stock Price History:
The Beta on a monthly basis for IRWD is 0.31, which has changed by -0.73115945 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, IRWD has reached a high of $15.70, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is -2.46%, while the 200-Day Moving Average is calculated to be -28.02%.
Shares Statistics:
It appears that IRWD traded 1.95M shares on average per day over the past three months and 1501540 shares per day over the past ten days. A total of 160.02M shares are outstanding, with a floating share count of 155.54M. Insiders hold about 2.81% of the company’s shares, while institutions hold 103.18% stake in the company. Shares short for IRWD as of 1735603200 were 9217937 with a Short Ratio of 4.72, compared to 1732838400 on 11218535. Therefore, it implies a Short% of Shares Outstanding of 9217937 and a Short% of Float of 11.129999999999999.
